• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There is a lack of information about how long-term exposure to these medications may affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological disorders such as hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality studies.

Risk/Benefit Analysis

Pregnant women who use natural adhd medication medications must weigh the advantages of taking them against potential risks to the foetus. Doctors don't have the necessary data to give clear guidelines but they can provide information on benefits and risks that can help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at higher risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based case control study to assess the frequency of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure an accurate case classification and to minimize the possibility of bias.

However, the researchers' study was not without its flaws. Most important, they were unable to distinguish the effects of the medication from the effects of the disorder at hand. That limitation makes it difficult to know whether the limited associations observed in the exposed groups are due to medication use or comorbidities that cause confusion. Researchers also did not examine the long-term effects for the offspring.

The study revealed that infants whose mother took ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU) in comparison to mothers who did not take any medication during pregnancy or had quit taking the medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not affected by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy were also at an elevated risk of having a caesarean section or having a baby with a low Apgar score (less than 7). These increases appeared to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medications during early pregnancies may be offset by the greater benefits to both baby and mother of continued treatment for the woman's disorder. Physicians should speak with their patients about this and try to help them develop coping skills that may reduce the effects of her disorder on her daily life and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to continue treatment or stop as more women are diagnosed with ADHD. Most of the time, these decisions are made without any evidence that is clear and definitive in either case, which means that doctors must weigh their knowledge from their own experiences, those of other doctors, and what the research suggests on the subject and their best adhd medication for adults judgment for each individual patient.

In particular, the issue of potential risks for the baby can be a challenge. The research that has been conducted on this topic is based on observations rather than controlled studies and the results are in conflict. The majority of studies focus on live births, which can doctors prescribe adhd medication underestimate the teratogenic impact that can lead to terminations or abortions of pregnancy. The study presented in this journal club addresses these shortcomings by looking at data from both live and deceased births.

The conclusion The conclusion: While some studies have shown that there is a positive correlation between ADHD medications and the possibility of certain birth defects, other studies have not found any evidence of a link and the majority of studies show a neutral or even slight negative effect. As a result, a careful risk/benefit assessment must be done in each case.

For many women with ADHD who suffer from ADHD, the decision to stop medication is difficult if not impossible. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of isolation. The loss of medication can affect the ability to drive safely and complete work-related tasks, which are crucial aspects of normal life for people with ADHD.

She suggests that women who are unsure whether to take the medication or stop due to pregnancy, educate their family members, coworkers, and their friends about the condition, the effects on daily functioning, and the benefits of continuing the current treatment regimen. Educating them can also make the woman feel more comfortable when she is struggling dealing with adhd without medication her decision. It is important to remember that some drugs can pass through the placenta, so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the medication could be passed on to the baby.

Birth Defects and Risk of

As the use and use of buy adhd medication online medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD), increases, so does concern about the possible effects of the drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Researchers used two massive data sets to study over 4.3 million pregnancy and determine if the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists found that exposure in the first trimester to adhd medication not working medications was associated with a slightly higher rate of specific heart defects, such as ventriculo-septal defect (VSD).

The researchers of the study found no association between the use of early medications and congenital abnormalities like facial clefting, or club foot. The results are in the same vein as previous studies that showed a small, but significant increase in cardiac malformations for women who started taking ADHD medication prior to the time of pregnancy. The risk increased in the latter half of pregnancy, when a lot of women began to stop taking their medication.

Women who took ADHD medications during the first trimester of their pregnancies were also more likely to undergo caesarean section, low Apgar score following delivery, and a baby who required breathing assistance at birth. The researchers of the study could not eliminate selection bias because they restricted the study to women who did not have any other medical conditions that could have contributed to the findings.

The researchers hope their research will help inform the clinical decisions of physicians who see pregnant women. They suggest that although a discussion of the benefits and risks is important however, the decision to stop or continue medication should be based on the woman's needs and the severity of her ADHD symptoms.

The authors caution that, even though stopping the medication is an option to consider, it is not recommended due to the high prevalence of depression and mental health issues for women who are pregnant or who have recently given birth. Additionally, research suggests that women who stop taking their medication will have a difficult time adjusting to a life without them after the baby is born.

Nursing

It can be a stressful experience to become a mom. Women suffering from ADHD may face a lot of challenges when they have to manage their symptoms, go to doctor appointments, prepare for the birth of a baby and adjust to new routines. Therefore, many women choose to continue taking their ADHD medication throughout the pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medications is absorbed through breast milk at low levels. The rate of exposure to medication will differ based on dosage the medication is administered, its frequency and time of day. In addition, various medications enter the baby’s system via the gastrointestinal tract or breast milk. The impact on a newborn's health is not completely understood.

Because of the lack of research, some doctors might be tempted to stop taking stimulant drugs during the course of pregnancy. It is a difficult decision for the mother, who must weigh the benefits of taking her medication as well as the risk to the embryo. Until more information becomes available, doctors may ask pregnant patients whether they have an background of ADHD or if they intend to take medication during the perinatal stage.

Numerous studies have demonstrated that women can continue taking their ADHD medication without risk while breastfeeding and during pregnancy. In the end, more and more patients are choosing to do so and, after consulting with their doctor, they have discovered that the benefits of maintaining their current medication outweigh any risks.

Women who suffer from ADHD who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor, and the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be offered to help pregnant people with ADHD be aware of their symptoms and underlying disorder and learn about treatment options and reinforce existing strategies for managing. This should be a multidisciplinary approach together with obstetricians, GPs and psychiatry. Pregnancy counselling should include the discussion of a treatment plan for both the mother and child, monitoring for signs of deterioration and the need for adjustments to the medication regimen.